OGN
NYSE
$13.49
Organon & Company (OGN)
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, Hormone replacement therapy (HRT), and anesthesia. The company sells to international markets.
Sector:
Healthcare
Industry:
Drug Manufacturers - General
Hold
Target: $11.25 (-16.60%)
Market Cap
$3.54B
Forward P/E
5.09
P/E Ratio
14.33
Free Cash Flow Yield
19.28%
Price Chart
Valuation
Market Cap$3.54B
P/E14.33
Forward P/E5.09
P/S0.57
P/B3.93
Profitability
Total Revenue (TTM)$6.16B
Gross Profit (TTM)$3.32B
EBITDA$1.19B
Profit Margin10%
Operating Margin18.2%
EPS$0.94
Financial Health
Debt-to-Equity948.9%
Free Cash Flow Yield19.28%
Dividend Yield0.59%
Growth & Risk
EPS 5Y CAGR-35.81%
Revenue 5Y CAGR-0.31%
Beta (5Y)0.85
Sharpe Ratio0.77